−0.31USD
−20.94 MUSD
70.65 M
About Oncolytics Biotech Inc.
Sector
Industry
CEO
Matthew C. Coffey
Website
Headquarters
Calgary
Founded
1998
ISIN
CA6823108759
FIGI
BBG000DVS826
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ONCY is 1.03 USD — it has decreased by 0.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Oncolytics Biotech Inc. stocks are traded under the ticker ONCY.
Oncolytics Biotech Inc. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
ONCY stock is 3.92% volatile and has beta coefficient of −0.57. Check out the list of the most volatile stocks — is Oncolytics Biotech Inc. there?
One year price forecast for Oncolytics Biotech Inc. has a max estimate of 6.63 USD and a min estimate of 2.21 USD.
ONCY earnings for the last quarter are −0.10 USD whereas the estimation was −0.08 USD which accounts for −31.01% surprise. Estimated earnings for the next quarter are −0.11 USD. See more details about Oncolytics Biotech Inc. earnings.
Yes, you can track Oncolytics Biotech Inc. financials in yearly and quarterly reports right on TradingView.
ONCY stock has fallen by 8.04% compared to the previous week, the month change is a 0.98% rise, over the last year Oncolytics Biotech Inc. has showed a 10.43% decrease.
ONCY net income for the last quarter is −2.98 M USD, while the quarter before that showed −7.31 M USD of net income which accounts for 59.22% change. Track more Oncolytics Biotech Inc. financial stats to get the full picture.
Today Oncolytics Biotech Inc. has the market capitalization of 78.85 M, it has increased by 11.17% over the last week.
No, ONCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ONCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncolytics Biotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncolytics Biotech Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncolytics Biotech Inc. stock shows the sell signal. See more of Oncolytics Biotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Oncolytics Biotech Inc. future price: according to them, ONCY price has a max estimate of 6.63 USD and a min estimate of 2.21 USD. Read a more detailed Oncolytics Biotech Inc. forecast: see what analysts think of Oncolytics Biotech Inc. and suggest that you do with its stocks.